$134 Million is the total value of Lamond Capital Partners LLC's 14 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | Buy | AMGEN INC | $26,007,000 | +88.0% | 175,000 | +75.0% | 12.97% | +25.3% |
| AMGN | AMGEN INCcall | $20,748,000 | 0.0% | 150,000 | 0.0% | 10.35% | -33.4% | |
| ORCL | New | ORACLE CORP | $18,265,000 | – | 500,000 | +100.0% | 9.11% | – |
| ORCL | ORACLE CORPcall | $18,060,000 | 0.0% | 500,000 | 0.0% | 9.01% | -33.4% | |
| ABBV | New | ABBVIE INC | $17,772,000 | – | 300,000 | +100.0% | 8.86% | – |
| OCUL | OCULAR THERAPEUTIX INC | $17,340,000 | 0.0% | 1,233,285 | 0.0% | 8.65% | -33.4% | |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $17,309,000 | – | 220,780 | +100.0% | 8.63% | – |
| ALXN | ALEXION PHARMACEUTICALS INC | $15,639,000 | 0.0% | 100,000 | 0.0% | 7.80% | -33.4% | |
| ABBV | ABBVIE INCcall | $13,603,000 | 0.0% | 250,000 | 0.0% | 6.78% | -33.4% | |
| GWPH | GW PHARMACEUTICALS PLCads | $10,964,000 | 0.0% | 120,000 | 0.0% | 5.47% | -33.4% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10,532,000 | 0.0% | 100,000 | 0.0% | 5.25% | -33.4% | |
| CY | CYPRESS SEMICONDUCTOR CORP | $9,372,000 | 0.0% | 1,100,000 | 0.0% | 4.67% | -33.4% | |
| KITE | KITE PHARMA INCcall | $3,530,000 | 0.0% | 63,400 | 0.0% | 1.76% | -33.4% | |
| RXDX | New | IGNYTA INC | $626,000 | – | 46,721 | +100.0% | 0.31% | – |
| ZLTQ | New | ZELTIQ AESTHETICS INC | $460,000 | – | 16,119 | +100.0% | 0.23% | – |
| IMMU | New | IMMUNOMEDICS INC | $307,000 | – | 100,000 | +100.0% | 0.15% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INFOBLOX INC | 6 | Q2 2015 | 19.8% |
| AMGEN INC | 5 | Q4 2015 | 15.1% |
| OCULAR THERAPEUTIX INC | 5 | Q4 2015 | 19.3% |
| LINKEDIN CORP | 5 | Q3 2014 | 12.2% |
| FIDELITY NATL INFORMATION SV | 5 | Q2 2014 | 9.7% |
| MASTERCARD INC | 5 | Q2 2014 | 7.4% |
| GOOGLE INC | 4 | Q1 2014 | 12.0% |
| GW PHARMACEUTICALS PLC | 4 | Q4 2015 | 17.1% |
| SALESFORCE COM INC | 4 | Q4 2014 | 11.6% |
| INFORMATICA CORP | 4 | Q1 2014 | 9.1% |
View Lamond Capital Partners LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2016-07-19 |
| 13F-HR | 2016-05-05 |
| 13F-HR/A | 2016-02-09 |
| 13F-HR | 2016-02-09 |
| 13F-HR | 2015-11-09 |
| 13F-HR | 2015-08-07 |
| 13F-HR | 2015-05-12 |
| 13F-HR | 2015-02-13 |
| 13F-HR | 2014-11-07 |
| 13F-HR | 2014-08-06 |
View Lamond Capital Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.
Compare quarters
The following issues were detected while analyzing the report:
- The reported total value is incorrect (133828000.0 != 200534000.0)
- The reported number of holdings is incorrect (14 != 17)
- The reported has been restated
- The reported has been amended
Export Lamond Capital Partners LLC's holdings